Jurnal
SINTA 1
Clinical Outcome Following Prolonged Neoadjuvant Chemotherapy and Delayed Surgery in Osteosarcoma Patients: An Evidence-based Clinical Review
ACTA MEDICA INDONESIANA · Vol. 54 No. 1 (2022)
ISSN 2338-2732, 0125-9326
Terbit 2022-04-08
Penerbit The Indonesian Society of Internal Medicine
Bahasa eng
Abstrak
Background: The incidence of osteosarcoma reached 16.8 cases annually at dr. Cipto Mangunkusumo Hospital in 1995-2008. Previous studies suggested that prolonged neoadjuvant chemotherapy followed by delayed surgery improves the clinical outcome. Prolonged neoadjuvant chemotherapy followed by delayed surgery commonly occurs in Indonesia, as diagnostic imaging and surgery waiting list will delay the surgery. The aim of this study is to observe the survival rate and the event-free survival rate of osteosarcoma patients with prolonged neoadjuvant chemotherapy and delayed surgery. Methods: This review included randomized controlled trials (RCTs), cohort studies, retrospective cohort studies, clinical trials, and reviews. Literature search was conducted through MEDLINE (PubMed search engine), Cochrane Central Register of Controlled Trial, and Scopus. The studies were screened and selected according to inclusion criteria by author and contributors independently. Results: Six studies were included in the qualitative synthesis of this study. Overall survival rate, event-free survival rate, histological response and recurrence as well as neoadjuvant chemotherapy duration, cycle and regiment were assessed in this study. Conclusion: Prolonged neoadjuvant chemotherapy and delayed surgery results in 5-years survival rate of 43.2% to 96.6% and 5-years event-free survival rate of 35.7% to 86.4%.
Jaringan kolaborasi para penulis
16 penulis ·
62 tautan kepenulisan bersama
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
Universitas Teknologi Sumbawa Afiliasi tidak diketahui
Organisasi berbeda
Organisasi sama
Afiliasi tidak diketahui
Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.
Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title xml:lang="en-US">Clinical Outcome Following Prolonged Neoadjuvant Chemotherapy and Delayed Surgery in Osteosarcoma Patients: An Evidence-based Clinical Review</dc:title>
<dc:creator>Sugito, Waluyo</dc:creator>
<dc:creator>Kamal, Achmad Fauzi</dc:creator>
<dc:subject xml:lang="en-US">Osteosarcoma</dc:subject>
<dc:subject xml:lang="en-US">neoadjuvant chemotherapy</dc:subject>
<dc:subject xml:lang="en-US">delayed surgery</dc:subject>
<dc:subject xml:lang="en-US">osteosarcoma</dc:subject>
<dc:description xml:lang="en-US">Background: The incidence of osteosarcoma reached 16.8 cases annually at dr. Cipto Mangunkusumo Hospital in 1995-2008. Previous studies suggested that prolonged neoadjuvant chemotherapy followed by delayed surgery improves the clinical outcome. Prolonged neoadjuvant chemotherapy followed by delayed surgery commonly occurs in Indonesia, as diagnostic imaging and surgery waiting list will delay the surgery. The aim of this study is to observe the survival rate and the event-free survival rate of osteosarcoma patients with prolonged neoadjuvant chemotherapy and delayed surgery. Methods: This review included randomized controlled trials (RCTs), cohort studies, retrospective cohort studies, clinical trials, and reviews. Literature search was conducted through MEDLINE (PubMed search engine), Cochrane Central Register of Controlled Trial, and Scopus. The studies were screened and selected according to inclusion criteria by author and contributors independently. Results: Six studies were included in the qualitative synthesis of this study. Overall survival rate, event-free survival rate, histological response and recurrence as well as neoadjuvant chemotherapy duration, cycle and regiment were assessed in this study. Conclusion: Prolonged neoadjuvant chemotherapy and delayed surgery results in 5-years survival rate of 43.2% to 96.6% and 5-years event-free survival rate of 35.7% to 86.4%. </dc:description>
<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
<dc:date>2022-04-08</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:type xml:lang="en-US">Evidence-Based Clinical Review</dc:type>
<dc:format>application/pdf</dc:format>
<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/1530</dc:identifier>
<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 54 No. 1 (2022): Acta Medica Indonesiana; 142</dc:source>
<dc:source>2338-2732</dc:source>
<dc:source>0125-9326</dc:source>
<dc:language>eng</dc:language>
<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/1530/pdf</dc:relation>
<dc:rights xml:lang="en-US">Copyright (c) 2022 Acta Medica Indonesiana</dc:rights>
</oai_dc:dc>
Sitasi dan pengindeksan
OpenAlex
Belum diperiksa
Crossref
Tidak ditemukan
Jumlah menurut tiap indeks pada 9 Nov 2026; setiap indeks menghitung sitasi dengan cara berbeda.
Sitasi artikel ini
APA 7
Sugito, W., & Kamal, A. F. (2022). Clinical Outcome Following Prolonged Neoadjuvant Chemotherapy and Delayed Surgery in Osteosarcoma Patients: An Evidence-based Clinical Review. ACTA MEDICA INDONESIANA, 54(1). http://www.actamedindones.org/index.php/ijim/article/view/1530
Salin
IEEE
W. Sugito and A. F. Kamal, “Clinical Outcome Following Prolonged Neoadjuvant Chemotherapy and Delayed Surgery in Osteosarcoma Patients: An Evidence-based Clinical Review,” ACTA MEDICA INDONESIANA, vol. 54, no. 1, 2022.
Salin
Dibuat dari metadata jurnal; periksa nama penulis sebelum dipakai.